Non-Hematopoietic MLKL protects against Salmonella mucosal infection by enhancing inflammasome activation

Frontiers in Immunology

Volumn 9, Issue FEB, 2018, Pages

  Yu, Shui Xing ^a   Chen, Wei ^a   Liu, Zhen Zhen ^a   Zhou, Feng Hua ^a   Yan, Shi Qing ^a   Hu, Gui Qiu ^a   Qin, Xiao Xia ^a   Zhang, Jie ^a   Ma, Ke ^a   Du, Chong Tao ^a   Deng, Xu Ming ^a   Han, Wen Yu ^a   Yang, Yong Jun ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Colitis; Gasdermin D; Inflammasome; Mixed lineage kinase like protein; Salmonella

Indexed keywords

GASDERMIN D; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; MIXED LINEAGE KINASE LIKE PROTEIN; PROTEIN; RECOMBINANT INTERLEUKIN 18; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BONE MARROW CELL; COLITIS; CONTROLLED STUDY; CRYPT CELL; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; INTESTINE INFECTION; INTESTINE MUCOSA PERMEABILITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SALMONELLOSIS; WESTERN BLOTTING;

EID: 85041851801     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.00119     Document Type: Article

References (61)

1. Nordlander S, Pott J, Maloy KJ. NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen. Mucosal Immunol (2014) 7:775-85. doi:10.1038/mi.2013.95
2. Yang JY, Kim MS, Kim E, Cheon JH, Lee YS, Kim Y, et al. Enteric viruses ameliorate gut inflammation via toll-like receptor 3 and toll-like receptor 7-mediated interferon-beta production. Immunity (2016) 44:889-900. doi:10.1016/j.immuni.2016.03.009
3. Boyle EC, Bishop JL, Grassl GA, Finlay BB. Salmonella: from pathogenesis to therapeutics. J Bacteriol (2007) 189:1489-95. doi:10.1128/JB.01730-06
4. Lawley TD, Walker AW. Intestinal colonization resistance. Immunology (2013) 138:1-11. doi:10.1111/j.1365-2567.2012.03616.x
5. Broz P, Ohlson MB, Monack DM. Innate immune response to Salmonella typhimurium, a model enteric pathogen. Gut Microbes (2012) 3:62-70. doi:10.4161/gmic.19141
6. Ahmer BM, Gunn JS. Interaction of Salmonella spp. with the intestinal microbiota. Front Microbiol (2011) 2:101. doi:10.3389/fmicb.2011.00101
7. Corr SC, Palsson-McDermott EM, Grishina I, Barry SP, Aviello G, Bernard NJ, et al. MyD88 adaptor-like (Mal) functions in the epithelial barrier and contributes to intestinal integrity via protein kinase C. Mucosal Immunol (2014) 7:57-67. doi:10.1038/mi.2013.24
8. Hu GQ, Song PX, Li N, Chen W, Lei QQ, Yu SX, et al. AIM2 contributes to the maintenance of intestinal integrity via Akt and protects against Salmonella mucosal infection. Mucosal Immunol (2016) 9:1330-9. doi:10.1038/mi.2015.142
9. Schultz BM, Paduro CA, Salazar GA, Salazar-Echegarai FJ, Sebastián VP, Riedel CA, et al. A potential role of Salmonella infection in the onset of inflammatory bowel diseases. Front Immunol (2017) 8:191. doi:10.3389/fimmu.2017.00191
10. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol (2010) 10:131-44. doi:10.1038/nri2707
11. Opipari A, Franchi L. Role of inflammasomes in intestinal inflammation and crohn's disease. Inflamm Bowel Dis (2015) 21:173-81. doi:10.1097/MIB.0000000000000230
12. Man SM, Zhu Q, Zhu L, Liu Z, Karki R, Malik A, et al. Critical role for the DNA sensor AIM2 in stem cell proliferation and cancer. Cell (2015) 162:45-58. doi:10.1016/j.cell.2015.06.001
13. Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of the 'epimmunome'. Nat Immunol (2010) 11:656-65. doi:10.1038/ni.1905
14. Wu J, Huang Z, Ren J, Zhang Z, He P, Li Y, et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res (2013) 23:994-1006. doi:10.1038/cr.2013.91
15. Yu SX, Zhou FH, Chen W, Jiang GM, Du CT, Hu GQ, et al. Decidual stromal cell necroptosis contributes to polyinosinic-polycytidylic acid-triggered abnormal murine pregnancy. Front Immunol (2017) 8:916. doi:10.3389/fimmu.2017.00916
16. Murphy JM, Vince JE. Post-translational control of RIPK3 and MLKL mediated necroptotic cell death. F1000Res (2015) 4:F1000 Faculty Rev-1297. doi:10.12688/f1000research.7046.1
17. Conos SA, Chen KW, De Nardo D, Hara H, Whitehead L, Núñez G, et al. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc Natl Acad Sci U S A (2017) 114:E961-9. doi:10.1073/pnas.1613305114
18. Weinlich R, Oberst A, Beere HM, Green DR. Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol (2017) 18:127-36. doi:10.1038/nrm.2016.149
19. Zhou W, Yuan J. Necroptosis in health and diseases. Semin Cell Dev Biol (2014) 35:14-23. doi:10.1016/j.semcdb.2014.07.013
20. Lamkanfi M, Dixit VM. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe (2010) 8:44-54. doi:10.1016/j.chom.2010.06.007
21. Ashida H, Mimuro H, Ogawa M, Kobayashi T, Sanada T, Kim M, et al. Cell death and infection: a double-edged sword for host and pathogen survival. J Cell Biol (2011) 195:931-42. doi:10.1083/jcb.201108081
22. Nogusa S, Thapa RJ, Dillon CP, Liedmann S, Oguin TH 3rd, Ingram JP, et al. RIPK3 activates parallel pathways of MLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza A virus. Cell Host Microbe (2016) 20:13-24. doi:10.1016/j.chom.2016.05.011
23. Barthel M, Hapfelmeier S, Quintanilla-Martínez L, Kremer M, Rohde M, Hogardt M, et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun (2003) 71:2839-58. doi:10.1128/IAI.71.5.2839-2858.2003
24. Lei QQ, Hu GQ, Chen W, Yu SX, Qi S, Du CT, et al. RCAN1 deficiency protects against Salmonella intestinal infection by modulating JNK activation. Mol Immunol (2016) 77:26-33. doi:10.1016/j.molimm.2016.07.009
25. Oppong GO, Rapsinski GJ, Newman TN, Nishimori JH, Biesecker SG, Tükel ç. Epithelial cells augment barrier function via activation of the toll-like receptor 2/phosphatidylinositol 3-kinase pathway upon recognition of Salmonella enterica serovar typhimurium curli fibrils in the gut. Infect Immun (2013) 81:478-86. doi:10.1128/IAI.00453-12
26. Wu X, Sun L, Zha W, Studer E, Gurley E, Chen L, et al. HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells. Gastroenterology (2010) 138:197-209. doi:10.1053/j.gastro.2009.08.054
27. Kinnebrew MA, Buffie CG, Diehl GE, Zenewicz LA, Leiner I, Hohl TM, et al. Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity (2012) 36:276-87. doi:10.1016/j.immuni.2011.12.011
28. Zhu Y, Zhu M, Lance P. iNOS signaling interacts with COX-2 pathway in colonic fibroblasts. Exp Cell Res (2012) 318:2116-27. doi:10.1016/j.yexcr.2012.05.027
29. Zarepour M, Bhullar K, Montero M, Ma C, Huang T, Velcich A, et al. The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar typhimurium colitis. Infect Immun (2013) 81:3672-83. doi:10.1128/IAI.00854-13
30. Yan L, Yang C, Tang J. Disruption of the intestinal mucosal barrier in Candida albicans infections. Microbiol Res (2013) 168:389-95. doi:10.1016/j.micres.2013.02.008
31. Thuijls G, Derikx JP, de Haan JJ, Grootjans J, de Bruïne A, Masclee AA, et al. Urine-based detection of intestinal tight junction loss. J Clin Gastroenterol (2010) 44:e14-9. doi:10.1097/MCG.0b013e31819f5652
32. Sellin ME, Müller AA, Felmy B, Dolowschiak T, Diard M, Tardivel A, et al. Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa. Cell Host Microbe (2014) 16:237-48. doi:10.1016/j.chom.2014.07.001
33. Reuter BK, Pizarro TT. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe? Eur J Immunol (2004) 34:2347-55. doi:10.1002/eji.200425351
34. Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity (2010) 32:379-91. doi:10.1016/j.immuni.2010.03.003
35. Chudnovskiy A, Mortha A, Kana V, Kennard A, Ramirez JD, Rahman A, et al. Host-protozoan interactions protect from mucosal infections through activation of the inflammasome. Cell (2016) 167(444-456):e414. doi:10.1016/j.cell.2016.08.076
36. Knodler LA, Crowley SM, Sham HP, Yang H, Wrande M, Ma C, et al. Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe (2014) 16:249-56. doi:10.1016/j.chom.2014.07.002
37. Yu SX, Du CT, Chen W, Lei QQ, Li N, Qi S, et al. Genipin inhibits NLRP3 and NLRC4 inflammasome activation via autophagy suppression. Sci Rep (2015) 5:17935. doi:10.1038/srep17935
38. He WT, Wan H, Hu L, Chen P, Wang X, Huang Z, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res (2015) 25:1285-98. doi:10.1038/cr.2015.139
39. Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature (2016) 535:153-8. doi:10.1038/nature18629
40. Petrie EJ, Hildebrand JM, Murphy JM. Insane in the membrane: a structural perspective of MLKL function in necroptosis. Immunol Cell Biol (2017) 95:152-9. doi:10.1038/icb.2016.125
41. Pearson JS, Murphy JM. Down the rabbit hole: is necroptosis truly an innate response to infection? Cell Microbiol (2017) 19:e12750. doi:10.1111/cmi.12750
42. Santos RL, Zhang S, Tsolis RM, Kingsley RA, Adams LG, Bäumler AJ. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect (2001) 3:1335-44. doi:10.1016/S1286-4579(01)01495-2
43. Cornick S, Tawiah A, Chadee K. Roles and regulation of the mucus barrier in the gut. Tissue Barriers (2015) 3:e982426. doi:10.4161/21688370.2014.982426
44. Buckley A, Turner JR. Cell biology of tight junction barrier regulation and mucosal disease. Cold Spring Harb Perspect Biol (2018) 10:a029314. doi:10.1101/cshperspect.a029314
45. Qian XX, Peng JC, Xu AT, Zhao D, Qiao YQ, Wang TR, et al. Noncoding transcribed ultraconserved region (T-UCR) uc.261 participates in intestinal mucosa barrier damage in crohn's disease. Inflamm Bowel Dis (2016) 22:2840-52. doi:10.1097/MIB.0000000000000945
46. Barmeyer C, Fromm M, Schulzke JD. Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases. Pflugers Arch (2017) 469:15-26. doi:10.1007/s00424-016-1914-6
47. Landy J, Ronde E, English N, Clark SK, Hart AL, Knight SC, et al. Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J Gastroenterol (2016) 22:3117-26. doi:10.3748/wjg.v22.i11.3117
48. Boyle EC, Brown NF, Finlay BB. Salmonella enterica serovar typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function. Cell Microbiol (2006) 8:1946-57. doi:10.1111/j.1462-5822.2006.00762.x
49. Edelblum KL, Yan F, Yamaoka T, Polk DB. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis (2006) 12:413-24. doi:10.1097/01.MIB.0000217334.30689.3e
50. Negroni A, Cucchiara S, Stronati L. Apoptosis, necrosis, and necroptosis in the gut and intestinal homeostasis. Mediators Inflamm (2015) 2015:250762. doi:10.1155/2015/250762
51. Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Sawa H, Nakajima T, et al. Breakdown of intestinal mucosa via accelerated apoptosis increases intestinal permeability in experimental severe acute pancreatitis. J Surg Res (2006) 135:18-26. doi:10.1016/j.jss.2006.02.050
52. Chaïbi C, Cotte-Laffitte J, Sandré C, Esclatine A, Servin AL, Quéro AM, et al. Rotavirus induces apoptosis in fully differentiated human intestinal Caco-2 cells. Virology (2005) 332:480-90. doi:10.1016/j.virol.2004.11.039
53. Broz P. Getting rid of the bad apple: inflammasome-induced extrusion of Salmonella-infected enterocytes. Cell Host Microbe (2014) 16:153-5. doi:10.1016/j.chom.2014.07.010
54. Song-Zhao GX, Srinivasan N, Pott J, Baban D, Frankel G, Maloy KJ. Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen. Mucosal Immunol (2014) 7:763-74. doi:10.1038/mi.2013.94
55. Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev (2017) 277:61-75. doi:10.1111/imr.12534
56. Carvalho FA, Nalbantoglu I, Aitken JD, Uchiyama R, Su Y, Doho GH, et al. Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunol (2012) 5:288-98. doi:10.1038/mi.2012.8
57. Gutierrez KD, Davis MA, Daniels BP, Olsen TM, Ralli-Jain P, Tait SW, et al. MLKL activation triggers NLRP3-mediated processing and release of IL-1beta independently of gasdermin-D. J Immunol (2017) 198:2156-64. doi:10.4049/jimmunol.1601757
58. Pereira M, Tourlomousis P, Wright J, Monie TP, Bryant CE. CARD9 negatively regulates NLRP3-induced IL-1beta production on Salmonella infection of macrophages. Nat Commun (2016) 7:12874. doi:10.1038/ncomms12874
59. Diamond CE, Leong KWK, Vacca M, Rivers-Auty J, Brough D, Mortellaro A. Salmonella typhimurium-induced IL-1 release from primary human monocytes requires NLRP3 and can occur in the absence of pyroptosis. Sci Rep (2017) 7:6861. doi:10.1038/s41598-017-07081-3
60. De Jong HK, Koh GC, van Lieshout MH, Roelofs JJ, van Dissel JT, van der Poll T, et al. Limited role for ASC and NLRP3 during in vivo Salmonella typhimurium infection. BMC Immunol (2014) 15:30. doi:10.1186/s12865-014-0030-7
61. Rauch I, Deets KA, Ji DX, von Moltke J, Tenthorey JL, Lee AY, et al. NAIP-NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of caspase-1 and-8. Immunity (2017) 46:649-59. doi:10.1016/j.immuni.2017.03.016